BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15367408)

  • 21. Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.
    Nooka AK; Nabhan C; Zhou X; Taylor MD; Byrtek M; Miller TP; Friedberg JW; Zelenetz AD; Link BK; Cerhan JR; Dillon H; Sinha R; Shenoy PJ; Levy D; Dawson K; Hirata JH; Flowers CR
    Ann Oncol; 2013 Feb; 24(2):441-448. PubMed ID: 23041589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia].
    Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI
    Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.
    Sohani AR; Maurer MJ; Giri S; Pitcher B; Chadburn A; Said JW; Bartlett NL; Czuczman MS; Martin P; Rosenbaum CA; Jung SH; Leonard JP; Cheson BD; Hsi ED
    Am J Surg Pathol; 2021 Mar; 45(3):384-393. PubMed ID: 33136585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serbian lymphoma study group: demografic characteristics of 257 patients with follicular lymphoma.
    Simonović O; Mačukanović-Golubović L; Andjelić B; Antić D; Mihaljević B
    Vojnosanit Pregl; 2015 Jun; 72(6):483-8. PubMed ID: 26226718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
    Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
    Hematol Oncol; 2022 Apr; 40(2):297-301. PubMed ID: 34845733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
    Annunziata S; Cuccaro A; Tisi MC; Hohaus S; Rufini V
    Ann Nucl Med; 2018 Jun; 32(5):372-377. PubMed ID: 29464479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
    Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
    [No Abstract]   [Full Text] [Related]  

  • 33. High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.
    Procházka V; Faber E; Raida L; Langová K; Indrák K; Papajík T
    Leuk Lymphoma; 2012 Jul; 53(7):1306-10. PubMed ID: 22263569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
    Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
    Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
    Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
    Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
    Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
    J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of follicular lymphomas.
    Luminari S; Federico M
    Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse.
    Boyne DJ; Chua N; Owen C; Joe-Uzuegbu O; Shakir H; Gogna P; Jarada TN; Brenner DR; Elia-Pacitti J; Ewara EM; Cheung WY
    Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e277-e285. PubMed ID: 37331847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation.
    Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
    Hematol Oncol; 2021 Dec; 39(5):639-649. PubMed ID: 34494300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated soluble IL-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement.
    Iwamuro M; Shinagawa K; Okada H; Takata K; Yoshino T; Yamamoto K
    Clin Biochem; 2014 Feb; 47(3):191-5. PubMed ID: 24362271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.